NASDAQ:ALTS Janone (ALTS) Stock Price, News & Analysis $10.26 +0.69 (+7.21%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$10.20 -0.06 (-0.55%) As of 06/13/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock About Janone Stock (NASDAQ:ALTS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Janone alerts:Sign Up Key Stats Today's Range$9.19▼$10.8050-Day Range$3.77▼$10.2152-Week Range$1.29▼$10.95Volume305,701 shsAverage Volume229,068 shsMarket Capitalization$179.09 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.Read More… Receive ALTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Janone and its competitors with MarketBeat's FREE daily newsletter. Email Address ALTS Stock News HeadlinesALT5 Sigma Integrates Lightning Network with Voltage to Enable Instant Bitcoin PaymentsMay 27, 2025 | prnewswire.comSee More Headlines ALTS Stock Analysis - Frequently Asked Questions How have ALTS shares performed this year? Janone's stock was trading at $4.65 at the beginning of 2025. Since then, ALTS shares have increased by 120.6% and is now trading at $10.26. View the best growth stocks for 2025 here. Who are Janone's major shareholders? Janone's top institutional investors include Belvedere Trading LLC. Insiders that own company stock include Peter Tassiopoulos and Virland A Johnson. View institutional ownership trends. How do I buy shares of Janone? Shares of ALTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Janone own? Based on aggregate information from My MarketBeat watchlists, some other companies that Janone investors own include JIADE (JDZG), Hyzon Motors (HYZN), New Horizon Aircraft (HOVR), Hour Loop (HOUR), Gossamer Bio (GOSS), Genius Group (GNS) and Ford Motor (F). Company Calendar Today6/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ALTS Previous SymbolNASDAQ:ALTS CIK862861 WebN/A Phone(702) 997-5968Fax952-930-1800Employees170Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.81 million Net MarginsN/A Pretax Margin-312.94% Return on Equity-2,940.01% Return on Assets-39.81% Debt Debt-to-Equity Ratio1.96 Current Ratio0.75 Quick Ratio0.75 Sales & Book Value Annual Sales$18.05 million Price / Sales9.92 Cash FlowN/A Price / Cash FlowN/A Book Value($0.67) per share Price / Book-15.31Miscellaneous Outstanding Shares17,455,000Free Float13,380,000Market Cap$179.09 million OptionableN/A Beta2.31 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (NASDAQ:ALTS) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janone Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Janone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.